Cafocept Solution contains Cetrimide 0.6% w/v and Chlorhexidine Gluconate 0.3% w/v, a powerful broad-spectrum antiseptic formulation widely used for wound care, disinfection, and infection prevention. It helps effectively eliminate bacteria, fungi, and other pathogens from minor cuts, abrasions, and surgical sites.
Cetrimide acts as a detergent antiseptic, aiding in cleansing and removing debris from wounds, while Chlorhexidine provides potent bactericidal and fungicidal action, ensuring long-lasting protection against infection. The combination ensures both cleaning and sterilization in a single solution, simplifying wound care management.
Belonging to the dermatology and antiseptic segment, Cafocept Solution is in high demand among hospitals, clinics, surgical centers, and PCD pharma franchise networks. Its proven effectiveness, easy application, and strong safety profile make it a preferred antiseptic for healthcare professionals.
For PCD franchise and B2B partners, Cafocept Solution offers a high-demand, profitable opportunity. Its dual-action antiseptic formulation, clinical acceptance, and consistent demand in wound care and disinfection markets ensure strong margins and reliable business growth both domestically and internationally.